OMRON (6645) Q1 2027 earnings summary

Executive summary

• Consolidated revenue for Q1 FY2026 rose 26.1% year-over-year to ¥209.9bn, with operating profit up 226.0% to ¥18.9bn and net profit attributable to shareholders up 131.1% to ¥10.6bn, led by strong performance in Industrial Automation (IAB) and Healthcare (HCB) segments.

• IAB benefited from AI-driven semiconductor investments, while HCB saw robust sales of blood pressure monitors; Data Solutions (DSB) also posted growth, and Social Systems (SSB) remained flat.

• The company adopted IFRS from FY2026, restating prior period figures for comparability.

• DMB was classified as a discontinued operation following a spin-off and sale agreement.

• Full-year guidance for revenue, operating profit, and net profit was raised, reflecting a more favorable business environment, especially for IAB.

Financial highlights

• Q1 FY2026 revenue increased 26.1% year-over-year to ¥209.9bn; gross profit up 28.8% to ¥97.5bn; gross margin improved to 46.5%.

• Operating profit surged 226.0% year-over-year to ¥18.9bn; net profit attributable to shareholders rose 131.1% to ¥10.6bn.

• Basic earnings per share increased to ¥54.08 from ¥23.37 year-over-year.

• Comprehensive income surged 247.1% to ¥21.0bn.

• Q1 operating cash flow was ¥64.0bn, up ¥47.5bn year-over-year; free cash flow reached ¥33.7bn.

Outlook and guidance

• Full-year revenue forecast raised to ¥880.0bn (+14.6% year-over-year); operating profit forecast increased to ¥80.0bn (+41.7%); net profit guidance lifted to ¥40.5bn (+82.1%); EPS forecast at ¥294.97.

• Upward revisions reflect strong first-quarter results and favorable outlook for IAB, HCB, and DSB segments.

• Exchange rate assumptions updated to USD/JPY 155, EUR/JPY 180, CNY/JPY 23 for the remainder of the year.

• IAB expected to deliver significant growth, driven by robust capital investment in semiconductors and secondary batteries.

• SSB guidance revised downward due to intensified competition in the residential renewable energy market.